{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:08:48Z","timestamp":1792292928037,"version":"4.4.0"},"reference-count":183,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.clim.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T22:24:58Z","timestamp":1542061498000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-6595","authenticated-orcid":false,"given":"Reza","family":"Yazdani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Fekrvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Shahkarami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5658-2511","authenticated-orcid":false,"given":"Gholamreza","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobak","family":"Moazzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4838-0407","authenticated-orcid":false,"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2018.11.007_bb0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1542\/peds.28.2.182","article-title":"Recurrent bacterial infections and dysgamma-globulinemia: deficiency of 7S gamma-globulins in the presence of elevated 19S gamma-globulins. Report of two cases","volume":"28","author":"Rosen","year":"1961","journal-title":"Pediatrics"},{"key":"10.1016\/j.clim.2018.11.007_bb0010","first-page":"101","article-title":"Immunodeficiency with hyper-IgM (HIM)","volume":"3","author":"Notarangelo","year":"1992","journal-title":"Immunodeficiency Rev."},{"key":"10.1016\/j.clim.2018.11.007_bb0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12016-013-8378-7","article-title":"The hyper IgM syndromes","volume":"46","author":"Qamar","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0020","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1172\/JCI117476","article-title":"Hyper IgM syndrome associated with defective CD40-mediated B cell activation","volume":"94","author":"Conley","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2018.11.007_bb0025","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1084\/jem.20080789","article-title":"Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination","volume":"205","author":"P\u00e9ron","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0030","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","article-title":"Hyper IgM Syndrome: a Report from the USIDNET Registry","volume":"36","author":"Leven","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/adc.2008.149351","article-title":"Ataxia-telangiectasia patients presenting with hyper-IgM syndrome","volume":"94","author":"Noordzij","year":"2009","journal-title":"Arch. Dis. Childhood"},{"key":"10.1016\/j.clim.2018.11.007_bb0040","article-title":"Clinical implications of systematic phenotyping and exome sequencing in patients with primary antibody deficiency","author":"Abolhassani","year":"2018","journal-title":"Genet. Med.: Offl. J. Am. Coll. Med. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0045","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2012.06.012","article-title":"A novel homozygous mutation in recombination activating gene 2 in 2 relatives with different clinical phenotypes: Omenn syndrome and hyper-IgM syndrome","volume":"130","author":"Chou","year":"2012","journal-title":"J. Aller. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-017-0464-9","article-title":"International union of immunological societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity","volume":"38","author":"Picard","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0055","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1073\/pnas.90.6.2170","article-title":"Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM","volume":"90","author":"Fuleihan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10875-014-0001-z","article-title":"Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry","volume":"34","author":"Aghamohammadi","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1871530316666160724214418","article-title":"The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases","volume":"16","author":"Azizi","year":"2016","journal-title":"Endocr. Metab. Immun. Disord. Drug Targets"},{"key":"10.1016\/j.clim.2018.11.007_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","article-title":"Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)","volume":"102","author":"Revy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.clim.2018.11.007_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2018.11.007_bb0080","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1182\/blood-2010-03-274241","article-title":"Different molecular behavior of CD40 mutants causing hyper-IgM syndrome","volume":"116","author":"Lanzi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12026-014-8498-z","article-title":"Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery","volume":"60","author":"Modell","year":"2014","journal-title":"Immunol. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2018.11.007_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2249.2009.03954.x","article-title":"The European internet-based patient and research database for primary immunodeficiencies: results 2006\u20132008","volume":"157","author":"Gathmann","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1027382916924","article-title":"Primary immunodeficiency syndrome in Spain: first report of the National Registry in Children and Adults","volume":"17","author":"Matamoros Flori","year":"1997","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2018.11.007_bb0105","first-page":"123","article-title":"Morbidity and mortality of Iranian patients with hyper IgM syndrome: a clinical analysis","volume":"11","author":"Abolhassani","year":"2014","journal-title":"Iran. J. Immunol.: IJI"},{"key":"10.1016\/j.clim.2018.11.007_bb0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/ar3904","article-title":"Immunoglobulin class-switch recombination deficiencies","volume":"14","author":"Durandy","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2018.11.007_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2141.2010.08077.x","article-title":"Update on the hyper immunoglobulin M syndromes","volume":"149","author":"Davies","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2018.11.007_bb0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmii.2012.07.004","article-title":"X-linked hyper-IgM syndrome with CD40LG mutation: two case reports and literature review in Taiwanese patients","volume":"48","author":"Tsai","year":"2015","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.clim.2018.11.007_bb0125","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","article-title":"The hyper IgM syndrome--an evolving story","volume":"56","author":"Etzioni","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clim.2018.11.007_bb0130","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1172\/JCI3409","article-title":"Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome","volume":"102","author":"Agematsu","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2018.11.007_bb0135","first-page":"321","article-title":"The X-linked hyperimmunoglobulin M syndrome","volume":"35","author":"Fuleihan","year":"1998","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.clim.2018.11.007_bb0140","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.158.6.2576","article-title":"Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression","volume":"158","author":"Durandy","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0145","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1073\/pnas.221456898","article-title":"Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM","volume":"98","author":"Ferrari","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","article-title":"Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome","volume":"97","author":"Minegishi","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0155","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","article-title":"Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination","volume":"4","author":"Imai","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0160","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/cyto.a.22108","article-title":"The defect in humoral immunity in patients with Nijmegen breakage syndrome is explained by defects in peripheral B lymphocyte maturation","volume":"81","author":"Piatosa","year":"2012","journal-title":"Cytometry. Part A: J. Int. Soc. Anal. Cytol."},{"key":"10.1016\/j.clim.2018.11.007_bb0165","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.4049\/jimmunol.170.7.3707","article-title":"ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region","volume":"170","author":"Pan-Hammarstrom","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2005.02.003","article-title":"Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2","volume":"115","author":"Imai","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0175","article-title":"Comparison of common monogenic defects in a large predominantly antibody deficiency cohort","author":"Yazdani","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0180","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1073\/pnas.91.6.2110","article-title":"Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis","volume":"91","author":"Villa","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0185","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/eji.1830221226","article-title":"Cloning of TRAP, a ligand for CD40 on human T cells","volume":"22","author":"Graf","year":"1992","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0190","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","article-title":"Defects of class-switch recombination","volume":"117","author":"Notarangelo","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/IR:27:2-3:185","article-title":"CD154 transcriptional regulation in primary human CD4 T cells","volume":"27","author":"Cron","year":"2003","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2018.11.007_bb0200","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10875-013-9980-4","article-title":"First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes","volume":"34","author":"Cabral-Marques","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0205","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/INF.0b013e3182936280","article-title":"Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype","volume":"32","author":"Lee","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2018.11.007_bb0210","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","article-title":"Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0215","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2567.2006.02520.x","article-title":"Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L","volume":"120","author":"Van Hoeyveld","year":"2007","journal-title":"Immunology"},{"key":"10.1016\/j.clim.2018.11.007_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2018.11.007_bb0225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/smim.1998.0145","article-title":"CD40 and its crucial role as a member of the TNFR family","volume":"10","author":"Vogel","year":"1998","journal-title":"Semin. immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1067\/mpd.2003.41","article-title":"Disseminated cryptosporidium infection in an infant with hyper-IgM syndrome caused by CD40 deficiency","volume":"142","author":"Kutukculer","year":"2003","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2018.11.007_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00130832-200312000-00002","article-title":"Hyper-immunoglobulin-M syndromes caused by an intrinsic B cell defect","volume":"3","author":"Durandy","year":"2003","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0240","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nature01574","article-title":"Transcription-targeted DNA deamination by the AID antibody diversification enzyme","volume":"422","author":"Chaudhuri","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.clim.2018.11.007_bb0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.mam.2007.04.006","article-title":"DNA-uracil and human pathology","volume":"28","author":"Sousa","year":"2007","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12026-007-0023-1","article-title":"Immunodeficiencies due to defects of class-switch recombination","volume":"38","author":"Notarangelo","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2018.11.007_bb0255","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3858\/emm.2011.43.2.012","article-title":"Ligation of CD40 receptor in human B lymphocytes triggers the 5-lipoxygenase pathway to produce reactive oxygen species and activate p38 MAPK","volume":"43","author":"Ha","year":"2011","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0260","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","article-title":"Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility","volume":"34","author":"Crank","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0265","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.1243292","article-title":"Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage","volume":"342","author":"Angulo","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.clim.2018.11.007_bb0270","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","article-title":"Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome","volume":"134","author":"Kracker","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0275","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s10875-016-0281-6","article-title":"Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature","volume":"36","author":"Petrovski","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0280","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2015.04.014","article-title":"Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype","volume":"159","author":"Lougaris","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","article-title":"Mutations in PIK3R1 can lead to APDS2 SHORT syndrome or a combination of the two","volume":"179","author":"Garc\u00eda-Morato","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0290","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1172\/JCI75746","article-title":"A human immunodeficiency caused by mutations in the PIK3R1 gene","volume":"124","author":"Deau","year":"2014","journal-title":"J. Clin. invest."},{"key":"10.1016\/j.clim.2018.11.007_bb0295","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ni.2771","article-title":"Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency","volume":"15","author":"Lucas","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0300","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-\u03baB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0305","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/intimm\/dxf066","article-title":"Regulation of Ig class switch recombination by NF-kappaB: retroviral expression of RelB in activated B cells inhibits switching to IgG1, but not to IgE","volume":"14","author":"Bhattacharya","year":"2002","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0310","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","article-title":"Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia","volume":"2","author":"Jain","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/adc.73.2.185","article-title":"Ectodermal dysplasia and immunodeficiency","volume":"73","author":"Abinun","year":"1995","journal-title":"Arch. Dis. child."},{"key":"10.1016\/j.clim.2018.11.007_bb0320","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/316914","article-title":"A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)","volume":"67","author":"Zonana","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0330","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI18714","article-title":"A hypermorphic I\u03baB\u03b1 mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency","volume":"112","author":"Courtois","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2018.11.007_bb0335","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/humu.20740","article-title":"A novel mutation in NFKBIA\/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency","volume":"29","author":"Lopez-Granados","year":"2008","journal-title":"Human Mutat."},{"key":"10.1016\/j.clim.2018.11.007_bb0340","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.20040773","article-title":"The same I\u03baB\u03b1 mutation in two related individuals leads to completely different clinical syndromes","volume":"200","author":"Janssen","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(00)81174-5","article-title":"Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome","volume":"93","author":"Varon","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.clim.2018.11.007_bb0350","first-page":"406","article-title":"Ataxia-telangiectasia in twins presenting as autosomal recessive hyper-immunoglobulin M syndrome","volume":"9","author":"Etzioni","year":"2007","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.clim.2018.11.007_bb0355","first-page":"442","article-title":"Ataxia-telangiectasia in a patient presenting with hyper-immunoglobulin M syndrome","volume":"20","author":"Aghamohammadi","year":"2010","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0360","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/15321819.2014.891525","article-title":"Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM","volume":"36","author":"Mohammadinejad","year":"2015","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.clim.2018.11.007_bb0365","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/1744666X.2017.1292131","article-title":"The clinical significance of complete class switching defect in Ataxia telangiectasia patients","volume":"13","author":"Ghiasy","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0370","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","article-title":"Alterations of the X-linked lymphoproliferative disease geneSH2D1A in common variable immunodeficiency syndrome","volume":"98","author":"Morra","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0375","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1651-2227.1993.tb12773.x","article-title":"Immunodeficiency with increased immunoglobulin M associated with growth hormone insufficiency","volume":"82","author":"Ohzeki","year":"1993","journal-title":"Acta Paediatrica"},{"key":"10.1016\/j.clim.2018.11.007_bb0380","unstructured":"H.D. Ochs, Molecular Analysis of a Large Cohort of Patients with the Hyper IgM Syndrome (HIGM)."},{"key":"10.1016\/j.clim.2018.11.007_bb0385","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1182\/blood-2005-07-2955","article-title":"Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency","volume":"107","author":"Warnatz","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0390","doi-asserted-by":"crossref","first-page":"683160","DOI":"10.1155\/2014\/683160","article-title":"Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome","volume":"2014","author":"Wang","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.clim.2018.11.007_bb0395","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-009-9315-7","article-title":"Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations","volume":"29","author":"Aghamohammadi","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0400","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-3083.2010.02406.x","article-title":"Clinical and molecular characterization of X-linked hyper-IgM syndrome patients in China","volume":"72","author":"An","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0405","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.humimm.2014.04.014","article-title":"Clinical, molecular, and T cell subset analyses in a small cohort of Chinese patients with hyper-IgM syndrome type 1","volume":"75","author":"Tang","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0410","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10875-007-9089-8","article-title":"Clinical follow-up of 11 Argentinian CD40L-deficient patients with 7 unique mutations including the so-called \u201cmilder\u201d mutants","volume":"27","author":"Danielian","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0415","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcmd.2014.05.008","article-title":"X-linked hyper IgM syndrome: clinical, immunological and molecular features in patients from India","volume":"53","author":"Madkaikar","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.clim.2018.11.007_bb0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.0105-2896.2005.00222.x","article-title":"Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects","volume":"203","author":"Durandy","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2018.11.007_bb0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","article-title":"Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency","volume":"110","author":"Quartier","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00251-015-0878-6","article-title":"Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients","volume":"68","author":"Ouadani","year":"2016","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clim.2018.11.007_bb0435","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11882-001-0030-6","article-title":"The hyper IgM syndrome","volume":"1","author":"Fuleihan","year":"2001","journal-title":"Curr. Allergy Asthma Rep."},{"key":"10.1016\/j.clim.2018.11.007_bb0440","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1081-1206(10)60479-6","article-title":"Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment","volume":"100","author":"Ochs","year":"2008","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0445","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2008.08.018","article-title":"Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity","volume":"122","author":"Hanson","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0450","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clim.2005.08.005","article-title":"Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation","volume":"117","author":"Blaeser","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0455","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/515633","article-title":"Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome","volume":"178","author":"Seyama","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2018.11.007_bb0460","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1128\/IAI.67.7.3558-3565.1999","article-title":"Role of CD40 ligand in Mycobacterium avium infection","volume":"67","author":"Hayashi","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.clim.2018.11.007_bb0465","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1107::AID-IMMU1107>3.0.CO;2-0","article-title":"Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression","volume":"29","author":"Marriott","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0470","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.4049\/jimmunol.162.3.1618","article-title":"Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans","volume":"162","author":"Retini","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0475","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/1521-4141(200205)32:5<1455::AID-IMMU1455>3.0.CO;2-C","article-title":"CD40\/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide","volume":"32","author":"Netea","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0480","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jaci.2011.10.026","article-title":"Dendritic cells from X-linked hyper-IgM patients present impaired responses to Candida albicans and Paracoccidioides brasiliensis","volume":"129","author":"Cabral-Marques","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.clim.2018.11.007_bb0485","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s10875-008-9171-x","article-title":"Autoimmunity in hyper-IgM syndrome","volume":"28","author":"Jesus","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0490","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI18161","article-title":"Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination","volume":"112","author":"Imai","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.clim.2018.11.007_bb0495","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2223\/JPED.1460","article-title":"Response to polysaccharide antigens in patients with ataxia-telangiectasia","volume":"82","author":"Guerra-Maranhao","year":"2006","journal-title":"J. Pediatr. (Rio J)"},{"key":"10.1016\/j.clim.2018.11.007_bb0500","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T","article-title":"Bronchiectasis in Alaska Native children: causes and clinical courses","volume":"29","author":"Singleton","year":"2000","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.clim.2018.11.007_bb0505","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0974-2727.141510","article-title":"X-linked hyper-IgM syndrome with bronchiectasis","volume":"6","author":"Nandan","year":"2014","journal-title":"J. Lab. Physicians"},{"key":"10.1016\/j.clim.2018.11.007_bb0510","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jaci.2012.03.043","article-title":"Evaluation of a patient with hyper-IgM syndrome","volume":"129","author":"Uygungil","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0515","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1100\/2011\/671453","article-title":"The role of CD40\/CD40 ligand interactions in bone marrow granulopoiesis","volume":"11","author":"Mavroudi","year":"2011","journal-title":"Scient. World J."},{"key":"10.1016\/j.clim.2018.11.007_bb0520","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood.V95.12.3758.012k44_3758_3764","article-title":"CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells","volume":"95","author":"Solanilla","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0525","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0530","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpeds.2004.05.037","article-title":"Liver disease in children with primary immunodeficiencies","volume":"145","author":"Rodrigues","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2018.11.007_bb0535","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1084\/jem.20062287","article-title":"CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance","volume":"204","author":"Herve","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0540","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000453263","article-title":"Autoimmunity in primary antibody deficiencies","volume":"171","author":"Azizi","year":"2016","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0545","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.4049\/jimmunol.162.9.5601","article-title":"Defective self-reactive antibody repertoire of serum IgM in patients with hyper-IgM syndrome","volume":"162","author":"Lacroix-Desmazes","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0550","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/1744666X.2016.1177458","article-title":"Autoimmunity in primary T-cell immunodeficiencies","volume":"12","author":"Azizi","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0555","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09273940590928571","article-title":"Autoimmune retinopathy with RPE hypersensitivity and \u2018negative ERG\u2019in X-linked hyper-IgM syndrome","volume":"13","author":"Schuster","year":"2005","journal-title":"Ocular Immunol. Inflam."},{"key":"10.1016\/j.clim.2018.11.007_bb0560","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/sji.12506","article-title":"Approach to the management of autoimmunity in primary immunodeficiency","volume":"85","author":"Azizi","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0565","doi-asserted-by":"crossref","unstructured":"M.E. Maccari, H. Abolhassani, A. Aghamohammadi, A. Aiuti, O. Aleinikova, C. Bangs, S. Baris, F. Barzaghi, H. Baxendale, M. Buckland, S.O. Burns, C. Cancrini, A. Cant, P. Cathebras, M. Cavazzana, A. Chandra, F. Conti, T. Coulter, L.A. Devlin, J.D.M. Edgar, S. Faust, A. Fischer, M. Garcia-Prat, L. Hammarstrom, M. Heeg, S. Jolles, E. Karakoc-Aydiner, G. Kindle, A. Kiykim, D. Kumararatne, B. Grimbacher, H. Longhurst, N. Mahlaoui, T. Milota, F. Moreira, D. Moshous, A. Mukhina, O. Neth, B. Neven, A. Nieters, P. Olbrich, A. Ozen, J. Pachlopnik Schmid, C. Picard, S. Prader, W. Rae, J. Reichenbach, S. Rusch, S. Savic, A. Scarselli, R. Scheible, A. Sediva, S.O. Sharapova, A. Shcherbina, M. Slatter, P. Soler-Palacin, A. Stanislas, F. Suarez, F. Tucci, A. Uhlmann, J. van Montfrans, K. Warnatz, A.P. Williams, P. Wood, S. Kracker, A.M. Condliffe, S. Ehl, Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: The European Society for Immunodeficiencies-activated phosphoinositide 3-kinase delta syndrome registry, Front. Immunol., 9 (2018) 543.","DOI":"10.3389\/fimmu.2018.00543"},{"key":"10.1016\/j.clim.2018.11.007_bb0570","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5858\/2008-132-847-PDGNCA","article-title":"Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated with X-linked hyperimmunoglobulin M syndrome","volume":"132","author":"Malhotra","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0575","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.clim.2008.08.005","article-title":"Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature","volume":"129","author":"Erdos","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0580","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.5858\/2003-127-1200-NTCANC","article-title":"Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence","volume":"127","author":"Broaddus","year":"2003","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0585","first-page":"571","article-title":"BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder","volume":"10","author":"Hussain","year":"2003","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.clim.2018.11.007_bb0590","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V93.9.2999","article-title":"Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand","volume":"93","author":"Hirano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0595","first-page":"2261","article-title":"Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines","volume":"5","author":"Posner","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2018.11.007_bb0600","first-page":"95","article-title":"Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector","volume":"26","author":"Koppold","year":"2005","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.clim.2018.11.007_bb0605","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/jnci\/94.18.1381","article-title":"The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis","volume":"94","author":"Bugajska","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.clim.2018.11.007_bb0610","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cll.2004.12.001","article-title":"Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers","volume":"25","author":"Gologan","year":"2005","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0615","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1073\/pnas.0605715104","article-title":"Osteopenia in X-linked hyper-IgM syndrome reveals a regulatory role for CD40 ligand in osteoclastogenesis","volume":"104","author":"Lopez-Granados","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0620","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \"memory\" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0625","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3476(97)70139-2","article-title":"Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome","volume":"131","author":"Ameratunga","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2018.11.007_bb0630","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI117089","article-title":"Cyclosporin A inhibits CD40 ligand expression in T lymphocytes","volume":"93","author":"Fuleihan","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2018.11.007_bb0635","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2249.2000.01235.x","article-title":"Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome","volume":"120","author":"Inwald","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0640","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/eji.1830240831","article-title":"Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn","volume":"24","author":"Brugnoni","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0645","first-page":"S255","article-title":"Mycobacterial infections in tunisian primary immunodeficiency patients","volume":"34","author":"Mekki","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0650","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1073\/pnas.91.3.1099","article-title":"CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency","volume":"91","author":"Farrington","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0655","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tibs.2014.12.003","article-title":"Synergy in activating class I PI3Ks","volume":"40","author":"Burke","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.clim.2018.11.007_bb0660","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/CRIAI:19:2:205","article-title":"X-linked hyper IgM syndrome","volume":"19","author":"Schneider","year":"2000","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0665","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/petr.12538","article-title":"Hematopoietic stem cell transplant for hyper-IgM syndrome due to CD40L defects: A single-center experience","volume":"19","author":"Al-Saud","year":"2015","journal-title":"Pediatr. Transplant"},{"key":"10.1016\/j.clim.2018.11.007_bb0670","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2169\/internalmedicine.45.6023","article-title":"Progressive multifocal leukoencephalopathy complicating X-linked hyper-IgM syndrome in an adult","volume":"45","author":"Suzuki","year":"2006","journal-title":"Int. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0675","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2174\/1871530316666160724214418","article-title":"The use of immunoglobulin therapy in primary immunodeficiency diseases","volume":"16","author":"Azizi","year":"2016","journal-title":"Endocr. Metab. Immun. Disord.-Drug Targets"},{"key":"10.1016\/j.clim.2018.11.007_bb0680","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s10875-012-9720-1","article-title":"Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis","volume":"32","author":"Abolhassani","year":"2012","journal-title":"J. Clin. immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0685","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0690","first-page":"160","article-title":"Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor","volume":"16","author":"Wang","year":"1994","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.clim.2018.11.007_bb0695","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.inf.0000059402.81025.cd","article-title":"Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies","volume":"22","author":"Mclauchlin","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.clim.2018.11.007_bb0700","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM200002033420504","article-title":"Correction of the hyper-IgM syndrome after liver and bone marrow transplantation","volume":"342","author":"Hadzic","year":"2000","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0705","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"Festic","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.clim.2018.11.007_bb0710","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","article-title":"Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993\u20132002","volume":"103","author":"Gennery","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0715","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2012-02-400937","article-title":"Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans","volume":"120","author":"Candotti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0720","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.clim.2018.11.007_bb0725","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.clim.2018.11.007_bb0730","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/156652312799789253","article-title":"Gene therapy for severe combined immunodeficiency due to adenosine deaminase deficiency","volume":"12","author":"Montiel-Equihua","year":"2012","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.clim.2018.11.007_bb0735","doi-asserted-by":"crossref","first-page":"11310","DOI":"10.1074\/jbc.274.16.11310","article-title":"CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand","volume":"274","author":"Seyama","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2018.11.007_bb0740","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaci.2016.07.039","article-title":"Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation","volume":"139","author":"de la Morena","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0745","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2015.02.020","article-title":"Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan","volume":"136","author":"Mitsui-Sekinaka","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0750","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1056\/NEJM199508173330705","article-title":"Correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation","volume":"333","author":"Thomas","year":"1995","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0755","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10875-013-9951-9","article-title":"Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients","volume":"33","author":"Al-Saud","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0760","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-3476(03)00274-9","article-title":"Outcome of hematopoietic stem cell transplantation in hyper-IgM syndrome caused by CD40 deficiency","volume":"143","author":"Kutukculer","year":"2003","journal-title":"The Journal of pediatrics"},{"key":"10.1016\/j.clim.2018.11.007_bb0765","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.bor.0000231905.12172.b5","article-title":"Hyper-IgM syndromes","volume":"18","author":"Durandy","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2018.11.007_bb0770","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1023\/A:1023286807853","article-title":"Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome","volume":"18","author":"Atkinson","year":"1998","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0775","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0046-8177(96)90232-4","article-title":"Small cell undifferentiated carcinoma of the colon associated with hepatocellular carcinoma in an immunodeficient patient","volume":"27","author":"Zirkin","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.clim.2018.11.007_bb0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003033","article-title":"Activation-induced cytidine deaminase deficiency causes organ-specific autoimmune disease","volume":"3","author":"Hase","year":"2008","journal-title":"PloS one"},{"key":"10.1016\/j.clim.2018.11.007_bb0785","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","article-title":"Human disease resulting from gene mutations that interfere with appropriate nuclear factor-\u03baB activation","volume":"203","author":"Orange","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2018.11.007_bb0790","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1200\/JCO.2009.25.5067","article-title":"Child with ataxia telangiectasia developing acute myeloid leukemia","volume":"28","author":"Lin","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2018.11.007_bb0795","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.dnarep.2004.04.010","article-title":"Ataxia\u2013telangiectasia, an evolving phenotype","volume":"3","author":"Chun","year":"2004","journal-title":"DNA Rep."},{"key":"10.1016\/j.clim.2018.11.007_bb0800","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1385\/NMM:8:4:495","article-title":"Ataxia-telangiectasia and related diseases","volume":"8","author":"Frappart","year":"2006","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.clim.2018.11.007_bb0805","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","article-title":"Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype","volume":"128","author":"Micol","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0810","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.dnarep.2004.03.004","article-title":"Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks","volume":"3","author":"Digweed","year":"2004","journal-title":"DNA Rep."},{"key":"10.1016\/j.clim.2018.11.007_bb0815","first-page":"223","article-title":"Microcephaly with chromosomal instability and immunodeficiency--Nijmegen syndrome","volume":"71","author":"Chrzanowska","year":"1996","journal-title":"Pediatr. Polska"},{"key":"10.1016\/j.clim.2018.11.007_bb0820","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4049\/jimmunol.1102984","article-title":"Human MSH6 deficiency is associated with impaired antibody maturation","volume":"188","author":"Gardes","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0825","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012260","article-title":"Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID","volume":"5","author":"Offer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2018.11.007_bb0830","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaci.2014.08.030","article-title":"An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex","volume":"135","author":"Kracker","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0835","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0840","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0845","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1182\/blood-2008-02-141937","article-title":"Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes","volume":"113","author":"Salzer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2018.11.007_bb0850","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0855","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clim.2004.07.002","article-title":"ICOS deficiency in patients with common variable immunodeficiency","volume":"113","author":"Salzer","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0860","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaci.2010.10.019","article-title":"Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiency","volume":"127","author":"Vince","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2018.11.007_bb0865","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.clim.2018.11.007_bb0870","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ajhg.2012.04.015","article-title":"Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity","volume":"90","author":"Lopez-Herrera","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0875","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-&#x3ba;B1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0880","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.ejhg.5201634","article-title":"Linkage of autosomal-dominant common variable immunodeficiency to chromosome 4q","volume":"14","author":"Finck","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0885","doi-asserted-by":"crossref","unstructured":"M.J. Ombrello, E.F. Remmers, G. Sun, A.F. Freeman, S. Datta, P. Torabi-Parizi, N. Subramanian, T.D. Bunney, R.W. Baxendale, M.S. Martins, N. Romberg, H. Komarow, I. Aksentijevich, H.S. Kim, J. Ho, G. Cruse, M.-Y. Jung, A.M. Gilfillan, D.D. Metcalfe, C. Nelson, M. O'Brien, L. Wisch, K. Stone, D.C. Douek, C. Gandhi, A.A. Wanderer, H. Lee, S.F. Nelson, K.V. Shianna, E.T. Cirulli, D.B. Goldstein, E.O. Long, S. Moir, E. Meffre, S.M. Holland, D.L. Kastner, M. Katan, H.M. Hoffman, J.D. Milner, Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions, New Engl. J. Med., 366 (2012) 330\u2013338.","DOI":"10.1056\/NEJMoa1102140"},{"key":"10.1016\/j.clim.2018.11.007_bb0890","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2012.08.006","article-title":"A hypermorphic missense mutation in PLCG2, encoding phospholipase C&#x3b3;2, causes a dominantly inherited autoinflammatory disease with immunodeficiency","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0895","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.274.5284.97","article-title":"RAG mutations in human B cell-negative SCID","volume":"274","author":"Schwarz","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.clim.2018.11.007_bb0900","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1128\/MCB.20.15.5653-5664.2000","article-title":"Mutations in conserved regions of the predicted RAG2 kelch repeats block initiation of V(D)J recombination and result in primary immunodeficiencies","volume":"20","author":"Gomez","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2018.11.007_bb0905","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0092-8674(00)81448-8","article-title":"Partial V(D)J recombination activity leads to Omenn syndrome","volume":"93","author":"Villa","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.clim.2018.11.007_bb0910","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-0004.2004.00227.x","article-title":"Detection of RAG mutations and prenatal diagnosis in families presenting with either T\u2013B\u2013severe combined immunodeficiency or Omenn's syndrome","volume":"65","author":"Tabori","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.clim.2018.11.007_bb0915","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajmg.1320400309","article-title":"Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease","volume":"40","author":"Grierson","year":"1991","journal-title":"Am. J. Med. Genet."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618306399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618306399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:57:45Z","timestamp":1761494265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618306399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":183,"alternative-id":["S1521661618306399"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}